Conditions: Postmenopausal Osteoporosis
Keywords: Postmenopausal osteoporosis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 240

Brief summary:
To determine the effect and safety of menatetrenone on treatment of postmenopausal osteoporosis comparing with alfacalcidol.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: menatetranone intervention 2: alfacalcidol
Intervention descriptions: intervention 1: 15 mg three times a day orally for 12 months intervention 2: 0.25 μg twice a day orally for 12 months

Protocol document: